ATE278411T1 - Verfahren zur herstellung eines an wirkstoffen hochangereicherten extraktes der blätter von ginkgo biloba - Google Patents

Verfahren zur herstellung eines an wirkstoffen hochangereicherten extraktes der blätter von ginkgo biloba

Info

Publication number
ATE278411T1
ATE278411T1 AT02761922T AT02761922T ATE278411T1 AT E278411 T1 ATE278411 T1 AT E278411T1 AT 02761922 T AT02761922 T AT 02761922T AT 02761922 T AT02761922 T AT 02761922T AT E278411 T1 ATE278411 T1 AT E278411T1
Authority
AT
Austria
Prior art keywords
ginkgo biloba
biloba leaves
ethyl acetate
liquid
producing
Prior art date
Application number
AT02761922T
Other languages
English (en)
Inventor
Beng-Poon Teng
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE278411T1 publication Critical patent/ATE278411T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02761922T 2001-04-10 2002-04-09 Verfahren zur herstellung eines an wirkstoffen hochangereicherten extraktes der blätter von ginkgo biloba ATE278411T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104942A FR2823116B1 (fr) 2001-04-10 2001-04-10 Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
PCT/FR2002/001219 WO2002083158A1 (fr) 2001-04-10 2002-04-09 Procede de preparation d'un extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs

Publications (1)

Publication Number Publication Date
ATE278411T1 true ATE278411T1 (de) 2004-10-15

Family

ID=8862215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761922T ATE278411T1 (de) 2001-04-10 2002-04-09 Verfahren zur herstellung eines an wirkstoffen hochangereicherten extraktes der blätter von ginkgo biloba

Country Status (19)

Country Link
US (1) US7048954B2 (de)
EP (1) EP1379262B1 (de)
JP (1) JP4416404B2 (de)
KR (1) KR100876233B1 (de)
CN (1) CN1245167C (de)
AT (1) ATE278411T1 (de)
AU (1) AU2002307981B2 (de)
CA (1) CA2443302C (de)
CZ (1) CZ299652B6 (de)
DE (1) DE60201525T8 (de)
DK (1) DK1379262T3 (de)
ES (1) ES2230512T3 (de)
FR (1) FR2823116B1 (de)
HU (1) HUP0303797A3 (de)
NZ (1) NZ528571A (de)
PL (1) PL204867B1 (de)
PT (1) PT1379262E (de)
RU (1) RU2297235C2 (de)
WO (1) WO2002083158A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006040A1 (en) 2001-07-11 2003-01-23 The Trustees Of Columbia University In The City Of New York Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
WO2003082185A2 (en) 2002-03-29 2003-10-09 The Trustees Of Columbia University In The City Of New York Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof
JP2004307396A (ja) * 2003-04-07 2004-11-04 Kao Corp デオドラント剤
US7429670B2 (en) 2003-08-27 2008-09-30 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide C
WO2005046829A2 (en) 2003-11-12 2005-05-26 The Trustees Of Columbia University In The City Of New York Separation of ginkgolides and bilobalide from g. biloba
DE50307483D1 (de) * 2003-12-04 2007-07-26 Cognis Ip Man Gmbh Verfahren zur Herstellung von Extrakten des Ginkgo Biloba
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
CN1891242B (zh) * 2005-07-06 2012-01-04 徐州技源天然保健品有限公司 一种从银杏叶提取物中脱除多环芳烃的生产工艺
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
CZ299802B6 (cs) * 2006-10-12 2008-11-26 Kalvoda@Jaroslav Príprava zálivky obsahující extrakt z náprstníku cerveného, extrakt z jinanu dvoulalocného a dusicnan draselný, a její vliv na rostliny
ES2709633T3 (es) * 2007-12-21 2019-04-17 Dr Willmar Schwabe Gmbh & Co Kg Uso de un extracto de hojas de Ginkgo biloba
FR2926994B1 (fr) * 2008-02-06 2010-08-27 Sod Conseils Rech Applic Nouveau procede pour la preparation d'extraits de ginkgo biloba
WO2011012141A1 (en) * 2009-07-28 2011-02-03 Velleja Research S.R.L. Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用
FR3152724A1 (fr) * 2023-09-13 2025-03-14 Chromavis France Extrait de ginkgo biloba pour stimuler la croissance des cils

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044659C (zh) * 1987-06-30 1999-08-18 吴羽化学工业株式会社 含有唑类衍生物的农业和园艺用的农药组合物
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
JPH02193907A (ja) * 1989-01-19 1990-07-31 Daicel Chem Ind Ltd イチョウエキスの製法
KR940002796B1 (ko) * 1989-06-16 1994-04-02 주식회사 선경인더스트리 은행잎에서 징코라이드를 분리 및 정제하는 방법
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940095A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
GB9107425D0 (en) * 1991-04-09 1991-05-22 Scras Preparation of ginkgolide b
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
GB9408044D0 (en) * 1994-04-22 1994-06-15 Sod Conseils Rech Applic Conversion of ginkgolide c to ginkgolide b
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
DE19829516B4 (de) * 1998-07-02 2004-08-26 Dr. Willmar Schwabe Gmbh & Co. Kg Wasserlöslicher nativer Trockenextrakt aus Gingko biloba mit hohem Gehalt an Terpenoiden und Flavonglykosiden
CN1124275C (zh) * 2000-06-02 2003-10-15 天津大学 由银杏叶或银杏叶浸膏制备药物银杏内酯a、b的方法
ES2219259T3 (es) * 2000-06-16 2004-12-01 Linnea S.A. Complejo soluble en agua de un extracto de ginkgo biloba, procedimiento para su preparacion y composicion que lo comprende.
WO2003006040A1 (en) * 2001-07-11 2003-01-23 The Trustees Of Columbia University In The City Of New York Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
CN1287121C (zh) * 2004-04-05 2006-11-29 广东科龙电器股份有限公司 可实现冷媒充灌量动态控制的空调器节流装置

Also Published As

Publication number Publication date
JP4416404B2 (ja) 2010-02-17
NZ528571A (en) 2005-06-24
CN1501806A (zh) 2004-06-02
FR2823116A1 (fr) 2002-10-11
US7048954B2 (en) 2006-05-23
FR2823116B1 (fr) 2004-11-19
CZ20033055A3 (cs) 2004-06-16
DK1379262T3 (da) 2005-02-14
JP2004538263A (ja) 2004-12-24
HK1066164A1 (en) 2005-03-18
WO2002083158A1 (fr) 2002-10-24
CN1245167C (zh) 2006-03-15
US20040109907A1 (en) 2004-06-10
EP1379262A1 (de) 2004-01-14
DE60201525D1 (de) 2004-11-11
DE60201525T8 (de) 2006-08-24
ES2230512T3 (es) 2005-05-01
DE60201525T2 (de) 2006-03-02
KR100876233B1 (ko) 2008-12-26
HUP0303797A3 (en) 2005-05-30
PT1379262E (pt) 2005-02-28
RU2003132470A (ru) 2005-03-10
PL366938A1 (en) 2005-02-07
CZ299652B6 (cs) 2008-10-01
EP1379262B1 (de) 2004-10-06
KR20030087068A (ko) 2003-11-12
PL204867B1 (pl) 2010-02-26
RU2297235C2 (ru) 2007-04-20
CA2443302A1 (fr) 2002-10-24
CA2443302C (fr) 2012-09-18
AU2002307981B2 (en) 2006-11-23
HUP0303797A2 (hu) 2004-03-29

Similar Documents

Publication Publication Date Title
ATE278411T1 (de) Verfahren zur herstellung eines an wirkstoffen hochangereicherten extraktes der blätter von ginkgo biloba
CN109646371A (zh) 一种具有祛异味功效的组合物及其制备方法
CN110236981A (zh) 一种美白植物多糖组合物及其应用
CN103463953A (zh) 一种甲醛去除剂
DE60215671T2 (de) Verfahren zur isolierung von terpentrilactonen (ginkgoliden, bilobaliden) aus blättern und pharmazeutische pulver aus ginkgo biloba
US20080050457A1 (en) Ginkgo Biloba Extract And Method For Producing The Same
ATE309796T1 (de) Verfahren zur behandlung von augenerkrankungen
CN105541857A (zh) 一种汉防己甲素提取物及其制备方法和应用
JP3511057B2 (ja) 消臭剤
KR101025903B1 (ko) 후코이단 함유액의 변색 방법, 변색된 후코이단 함유액 및 이를 포함하는 민감성 피부용 화장품 조성물
RU2007143632A (ru) Способ получения экстракта из гинкго и экстрат гинкго билоба
JPH11290438A (ja) 消臭剤組成物
CN112062870B (zh) 一种具有美白保湿活性的多糖、含有该多糖的美白保湿面霜及其制备方法
JPH03227985A (ja) イチョウ葉からフラボノイドを高含有する抽出物の簡易な製造法
JPH05286845A (ja) 皮膚老化防止用化粧料
KR20140009688A (ko) 홍삼을 포함하는 발 샴푸 조성물
KR940018077A (ko) 화장료
JP2000212058A (ja) 皮膚化粧料、活性酸素消去剤、エラスタ―ゼ阻害剤およびコラゲナ―ゼ阻害剤
JP2731234B2 (ja) 香気性にすぐれかつ感作性の低いクローブ油の製造法
JPH02193907A (ja) イチョウエキスの製法
CN109875927A (zh) 龙胆提取物的应用
DE484139C (de) Kosmetisches Mittel
KR940013519A (ko) 은행잎으로부터 유효활성물질을 추출 정제하는 방법
JP2979606B2 (ja) 消臭剤およびその製造方法
DE397423C (de) Verfahren zur geruchlichen und geschmacklichen Verbesserung von Pfefferminzoelen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1379262

Country of ref document: EP

EEIH Change in the person of patent owner